OmniAsset
Get app

OmniAsset › Mutual funds › WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Pharma and Healthcare Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare TRI. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202617.646
CategorySectoral / Thematic
PlanDirect · Growth
Launched16 Jan 2024
Risk labelthe scheme's own riskometerVery High Risk
Legal benchmarkSEBI Tier-1BSE Healthcare TRI
Expense ratiodirect plan, a year1.10%
AUM₹133 Cr
Growth of ₹10,000₹17,5187 Feb 2024 to 2 Sep 2026
₹17,698₹15,685₹13,672₹11,659₹9,647Feb 2024Sep 2024May 2025Jan 2026Sep 2026
₹17,518 (+24.4% a year) WhiteOak Capital Pharma and Healthcare Fund

Performance (trailing, annualised)

1Y annualised24.43%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,43,55638.15%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 20251.84%

Rolling returns

Rolling 1Y · average81 windows since 10 Feb 202517.63%
Rolling 1Y · median18.40%
Rolling 1Y · worst window0.61%
Rolling 1Y · best window34.28%
Rolling 1Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)14.36%
Downside deviation (3Y)10.02%
Maximum drawdown-15.39%

Management

Fund managerMr. Ramesh Mantri, Mr. Piyush Baranwal, Mr. Dheeresh Pathak, Mr. Ashish Agrawal, Ms. Trupti Agrawal
Managing since6 Feb 2024

What it holds

SecurityWeight
Sun Pharmaceutical Industries Ltd8.5%
Torrent Pharmaceuticals Ltd7.8%
Laurus Labs Ltd4.9%
Apollo Hospitals Enterprise Ltd4.8%
Divi's Laboratories Ltd3.9%
Max Healthcare Institute Ltd3.8%
Cipla Ltd3.7%
Sai Life Sciences Ltd.3.2%
Zydus Lifesciences Ltd2.9%
Neuland Laboratories Ltd2.9%
SectorWeight
Healthcare89.7%
Materials4.8%
Financial3.4%

Portfolio disclosed: 97.8% by weight.

Related

Source: the OmniAsset signed reference snapshot, as of 3 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker